The Drug Discovery Industry Focus eBook, sponsored by Olink Proteomics, brings together expert perspectives on how emerging technologies, biomarker discovery strategies, and advanced research platforms are shaping modern drug development. As the pharmaceutical and biotechnology sectors continue to evolve, researchers are increasingly adopting data-driven approaches, AI-enabled tools, and sophisticated biological models to accelerate discovery while improving the precision and success of therapeutic development.
Download the Drug Discovery eBook Here
Biomarker research remains central to these advances. New approaches to biomarker identification are helping researchers gain a deeper understanding of disease mechanisms while refining clinical trial design. Digital biomarkers, including speech-based indicators in psychiatric research, illustrate how diverse data sources can improve early detection, patient stratification, and targeted therapy development. Predictive biomarkers are also becoming increasingly valuable for identifying which patients are most likely to respond to treatment, helping to optimize drug development pipelines.
At the same time, technological innovation is reshaping experimental workflows. Platforms such as microfluidic 3D organoid systems enable more physiologically relevant drug screening and toxicity studies, while artificial intelligence is streamlining complex processes such as antibody discovery and clone selection. New drug discovery platforms are also expanding researchers’ ability to identify first-in-class therapeutic candidates.
Together, these developments highlight the growing convergence of biology, technology, and data science in drug discovery. Sponsored by Olink Proteomics, this eBook highlights how collaborative innovation and advanced proteomics are helping researchers generate deeper biological insights and support the development of the next generation of precision medicines.
Download the Drug Discovery eBook Here
About Olink®- Part of Thermo Fisher Scientific
Olink’s mission is to accelerate proteomics together with the scientific community, to understand real-time biology and gain actionable insights into human health and disease. Our innovative solutions deliver highly sensitive and accurate protein quantification, giving scientists the power to investigate complex biological processes with precision.
One platform. Endless possibilities.
Explore up to 5,400 proteins with high specificity, transparent data, and the flexibility to answer any research question. Meet the next-generation proteomics platform trusted by the scientific community, from small academic research teams through to leading pharma companies.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.